EDIPASS-D Tablets

EDIPASS / D Tablets is an advanced anti-inflammatory and anti-edematous formulation from Orfit Pharmaceutical Pvt. Ltd., developed to provide effective relief from pain, swelling, and inflammation associated with injury, surgery, and musculoskeletal disorders. It contains a synergistic combination of Trypsin 48 mg, Bromelain 90 mg, and Rutoside Trihydrate 100 mg, with an additional variant that includes Diclofenac Potassium 50 mg for enhanced pain control. EDIPASS works by reducing inflammation and edema at the site of injury through enzymatic action, improving blood circulation, and accelerating the natural healing process. Trypsin and bromelain help break down inflammatory proteins and promote faster tissue repair, while rutoside strengthens capillaries and reduces swelling. The EDIPASS-D variant, with diclofenac potassium, provides added analgesic and anti-inflammatory benefits, making it especially useful in acute pain conditions. These tablets are commonly prescribed for post-operative swelling, sports injuries, soft tissue trauma, arthritis, dental surgery, and orthopedic conditions where pain and inflammation are prominent. Regular use under medical supervision helps improve mobility, reduces recovery time, and enhances patient comfort. Manufactured under stringent quality standards, EDIPASS / D reflects Orfit Pharmaceutical Pvt. Ltd.’s commitment to delivering reliable, effective, and clinically trusted solutions for inflammation and pain management.